Yumiko Kubota
Overview
Explore the profile of Yumiko Kubota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashizume H, Harada S, Sawa R, Iijima K, Kubota Y, Shibuya Y, et al.
J Antibiot (Tokyo)
. 2024 May;
77(7):475.
PMID: 38755397
No abstract available.
2.
Tatsukawa K, Sakamoto R, Kawasoe Y, Kubota Y, Tsurimoto T, Takahashi T, et al.
Nucleic Acids Res
. 2024 Feb;
52(6):3146-3163.
PMID: 38349040
Sensing and processing of DNA double-strand breaks (DSBs) are vital to genome stability. DSBs are primarily detected by the ATM checkpoint pathway, where the Mre11-Rad50-Nbs1 (MRN) complex serves as the...
3.
Hashizume H, Sawa R, Kubota Y, Adachi S, Harada S, Igarashi M
J Antibiot (Tokyo)
. 2024 Jan;
77(4):238-244.
PMID: 38267574
Tripropeptin C, a non-ribosomal cyclic lipopeptide containing three proline residues, exhibits excellent efficacy in the mouse-methicillin-resistant Staphylococcus aureus septicemia model. Since tripropeptins contain L-prolyl-D-proline and, as a result, are known...
4.
Maekawa K, Sawa R, Matsui M, Konda T, Kubota Y, Matsuo A, et al.
J AOAC Int
. 2023 Dec;
107(2):234-241.
PMID: 38070143
Background: Through the recent development of analytical technology, antibiotics quantification in the Japanese Pharmacopoeia (JP) has changed from traditional microbiological assays to physicochemical methods with high specificity and precision. However,...
5.
Yamasaki M, Sawa R, Muramatsu H, Yamamoto Y, Umekita M, Kubota Y, et al.
J Antibiot (Tokyo)
. 2023 Nov;
77(2):85-92.
PMID: 38008738
Hepatitis B virus (HBV) causes chronic hepatitis in humans, and current antiviral therapies rarely treat viral infections. To improve the treatment efficacy, novel therapeutic agents, especially those with different mechanisms...
6.
Ishizaki Y, Umekita M, Arisaka R, Hatano M, Kimura T, Kubota Y, et al.
J Antibiot (Tokyo)
. 2023 Sep;
76(12):691-698.
PMID: 37758819
Pseudomonas aeruginosa is one of the most concerning pathogenic bacteria. We screened antibiotics using a highly drug-sensitive P. aeruginosa strain and an oligotrophic medium, and successfully isolated novel antibiotics, namely...
7.
Mizuno Y, Ito T, Ueda K, Tashiro A, Kubota Y, Yamashita A, et al.
Clin J Gastroenterol
. 2022 Oct;
15(6):1193-1197.
PMID: 36264476
A 66-year-old Japanese woman had been diagnosed with a neuroendocrine tumor of the pancreatic head (G2) 3 years previously and undergone pancreaticoduodenectomy. Nine months postoperatively, recurrence with multiple liver metastases...
8.
Wada S, Arimura H, Nagayoshi M, Sawa R, Kubota Y, Matoba K, et al.
Adv Biol (Weinh)
. 2022 Mar;
6(6):e2101309.
PMID: 35297567
Nonreducing disaccharide trehalose is used as a stabilizer and humectant in various products and is a potential medicinal drug, showing curative effects on the animal models of various diseases. However,...
9.
Ito A, Suzuki K, Matsunaga K, Yagami A, Ito T, Tamagawa-Mineoka R, et al.
Contact Dermatitis
. 2021 Dec;
86(3):189-195.
PMID: 34921568
Background: The Japanese baseline series (JBS), established in 1994, was updated in 2008 and 2015. The JBS 2015 is a modification of the thin-layer rapid-use epicutaneous (TRUE) test (SmartPractice Denmark,...
10.
Kohda Y, Sakamoto S, Umekita M, Kimura T, Kubota Y, Arisaka R, et al.
J Antibiot (Tokyo)
. 2021 Dec;
75(2):77-85.
PMID: 34873311
New three macrocyclic diolides, named bispolides C-E (1-3), were isolated from a fermentation broth of the actinomycete strain MG372-hF19, which produces an indole glycoside and leptomycins as we reported previously....